Santa Rosa paint booth manufacturer Platinum Finishing Systems (PFS) exhibited at FABTECH 2026 in Las Vegas, Booth ...

Thank you for joining us and welcome to the Provident Financial Services third quarter 2026 earnings conference call. After ...

Regional bank Provident Financial Services (NYSE:PFS) met Wall Street’s revenue expectations in Q3 2026, with revenue up 7.6% ...

Adalimumab biosimilar Yuflyma PFS-S from Celltrion Pharm joins South Korea's NHI formulary at 220,390 Korean won per dose -- the lowest reimbursed adalimumab price in Korea -- featuring a passive ...

Sacituzumab govitecan extends survival in advanced endometrial cancer post chemotherapy and immunotherapy, per phase 3 data.

First-line pembrolizumab significantly improved PFS compared with chemotherapy alone for a subgroup of patients with endometrial cancer, according to results of the randomized phase 3 KEYNOTE-093 ...

YHB Principal Adrian Taylor discusses law firm profitability, tax planning, partner succession, cash flow management and the financial impact of AI.

The poster disclosed the median PFS data for tivunatamig combined with chemotherapy, with the data cutoff date updated to ...

A fresh FDA review for Biohaven’s embattled ataxia drug lifted the biotech's shares, while a late-stage lung cancer miss ...

HRE is targeting higher-value resources, Red Metal is testing heap-leach economics and St George is scaling up processing. ..

The results of a phase 3 trial suggest that a targeted therapy, known as sacituzumab tirumotecan (sac-TMT), was associated with a lower risk of progression and death of endometrial cancer.